BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36841949)

  • 1. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
    Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
    Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2975-2985. PubMed ID: 33454878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases.
    Taghavi M; Trebeschi S; Simões R; Meek DB; Beckers RCJ; Lambregts DMJ; Verhoef C; Houwers JB; van der Heide UA; Beets-Tan RGH; Maas M
    Abdom Radiol (NY); 2021 Jan; 46(1):249-256. PubMed ID: 32583138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
    Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
    Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT radiomics models are unable to predict new liver metastasis after successful thermal ablation of colorectal liver metastases.
    Taghavi M; Staal FC; Simões R; Hong EK; Lambregts DM; van der Heide UA; Beets-Tan RG; Maas M
    Acta Radiol; 2023 Jan; 64(1):5-12. PubMed ID: 34918955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
    Su X; Zhang H; Wang Y
    J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
    Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
    Front Oncol; 2022; 12():843991. PubMed ID: 35692757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer.
    Ma YQ; Wen Y; Liang H; Zhong JG; Pang PP
    World J Gastroenterol; 2021 Oct; 27(38):6465-6475. PubMed ID: 34720535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Machine Learning Benchmark Study for Radiomics-Based Survival Analysis of CT Imaging Data in Patients With Hepatic Metastases of CRC.
    Stüber AT; Coors S; Schachtner B; Weber T; Rügamer D; Bender A; Mittermeier A; Öcal O; Seidensticker M; Ricke J; Bischl B; Ingrisch M
    Invest Radiol; 2023 Dec; 58(12):874-881. PubMed ID: 37504498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation.
    van der Reijd DJ; Guerendel C; Staal FCR; Busard MP; De Oliveira Taveira M; Klompenhouwer EG; Kuhlmann KFD; Moelker A; Verhoef C; Starmans MPA; Lambregts DMJ; Beets-Tan RGH; Benson S; Maas M
    Eur Radiol; 2024 Jun; 34(6):3635-3643. PubMed ID: 37987835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.
    Dercle L; Lu L; Schwartz LH; Qian M; Tejpar S; Eggleton P; Zhao B; Piessevaux H
    J Natl Cancer Inst; 2020 Sep; 112(9):902-912. PubMed ID: 32016387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Lung Metastases Originated From Different Primary Tumors Using Radiomics Features Based on CT Imaging.
    Shang H; Li J; Jiao T; Fang C; Li K; Yin D; Zeng Q
    Acad Radiol; 2023 Jan; 30(1):40-46. PubMed ID: 35577699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of CT radiomics to predict treatment response of individual liver metastases in esophagogastric cancer patients.
    Klaassen R; Larue RTHM; Mearadji B; van der Woude SO; Stoker J; Lambin P; van Laarhoven HWM
    PLoS One; 2018; 13(11):e0207362. PubMed ID: 30440002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep learning-assisted magnetic resonance imaging prediction of tumor response to chemotherapy in patients with colorectal liver metastases.
    Zhu HB; Xu D; Ye M; Sun L; Zhang XY; Li XT; Nie P; Xing BC; Sun YS
    Int J Cancer; 2021 Apr; 148(7):1717-1730. PubMed ID: 33284998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer.
    Mühlberg A; Holch JW; Heinemann V; Huber T; Moltz J; Maurus S; Jäger N; Liu L; Froelich MF; Katzmann A; Gresser E; Taubmann O; Sühling M; Nörenberg D
    Eur Radiol; 2021 Feb; 31(2):834-846. PubMed ID: 32851450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases.
    Qu H; Zhai H; Zhang S; Chen W; Zhong H; Cui X
    Front Oncol; 2023; 13():992096. PubMed ID: 36814812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning.
    Tharmaseelan H; Vellala AK; Hertel A; Tollens F; Rotkopf LT; Rink J; Woźnicki P; Ayx I; Bartling S; Nörenberg D; Schoenberg SO; Froelich MF
    Cancer Imaging; 2023 Oct; 23(1):95. PubMed ID: 37798797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep radiomics-based fusion model for prediction of bevacizumab treatment response and outcome in patients with colorectal cancer liver metastases: a multicentre cohort study.
    Zhou S; Sun D; Mao W; Liu Y; Cen W; Ye L; Liang F; Xu J; Shi H; Ji Y; Wang L; Chang W
    EClinicalMedicine; 2023 Nov; 65():102271. PubMed ID: 37869523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting local tumour progression after ablation for colorectal liver metastases: CT-based radiomics of the ablation zone.
    Staal FCR; Taghavi M; van der Reijd DJ; Gomez FM; Imani F; Klompenhouwer EG; Meek D; Roberti S; de Boer M; Lambregts DMJ; Beets-Tan RGH; Maas M
    Eur J Radiol; 2021 Aug; 141():109773. PubMed ID: 34022475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.